Medical Device Connectivity

Abbott Plans to Acquire Bigfoot Biomedical, Growing Diabetes Portfolio

September 11, 2023 - Last week, Abbott announced plans to acquire Bigfoot Biomedical in the third quarter of 2023. If successful, this acquisition could significantly enhance Abbott’s diabetes management portfolio, adding new technology-driven tools to its repertoire. According to Abbott’s press release, Bigfoot Biomedical is a medical technology startup...


More Articles

Medidata, Labcorp Collaborate to Boost Digital Biomarker Discovery

by Samantha McGrail

Medidata and Labcorp Drug Development recently entered into an agreement to expand decentralized clinical trial capabilities and digital biomarker discovery. The companies will leverage Medidata...

FDA, Indian Government Stop 500 Illicit Prescription Drug Shipments

by Samantha McGrail

The FDA announced that Operation Broadsword, its enforcement operation with the Government of India, stopped nearly 500 shipments of illicit prescription drugs and medical devices from reaching...